Global Malaria Treatment Market, 2021-2027

January 2022 | 86 pages | ID: GA514B14E8F4EN
Gen Consulting Company

Abstracts

Malaria is a serious and sometimes fatal disease caused by a parasite that commonly infects a certain type of mosquito which feeds on humans. Globally, the WHO estimates that in 2020, 241 million clinical cases of malaria occurred, and 627,000 people died of malaria, most of them children in Africa. People who get malaria are typically very sick with high fevers, shaking chills, and flu-like illness. According to Gen Consulting Company, the global malaria treatment market size is expected to increase from USD 1,307 million in 2020 to USD 1,815 million by 2027, garnering a CAGR of 4.8% over the evaluated period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global malaria treatment market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The malaria treatment market is segmented on the basis of type, route of administration, end user, and region. The malaria treatment market is segmented as below:

By type:

• antimalarial agents (quinine, chloroquine, proguanil, mefloquine, pyrimethamine, others)
• diagnostic test (rapid diagnostic tests, microscopy, molecular diagnostic tests)

By route of administration:

• oral
• parenteral

By end user:

• hospitals
• specialty clinics
• others

By region:

• region
• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides analysis of the key companies of the industry and their detailed company profiles including Abbott Laboratories, Advanz Pharma Corp., Bayer AG, bioMerieux SA, Bio-Rad Laboratories, Inc., Cadila Healthcare Limited, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Ipca Laboratories Limited, Merck & Co., Inc., Meridian Bioscience Inc., Novartis International AG, Olympus Corporation, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global malaria treatment market.
• To classify and forecast the global malaria treatment market based on type, route of administration, end user, and region.
• To identify drivers and challenges for the global malaria treatment market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global malaria treatment market.
• To identify and analyze the profile of leading players operating in the global malaria treatment market.

Why Choose This Report

• Gain a reliable outlook of the global malaria treatment market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR MALARIA TREATMENT BY TYPE

5.1 Antimalarial agents (quinine, chloroquine, proguanil, mefloquine, pyrimethamine, others)
  5.1.1 Market size and forecast
5.2 Diagnostic test (rapid diagnostic tests, microscopy, molecular diagnostic tests)
  5.2.1 Market size and forecast

PART 6. GLOBAL MARKET FOR MALARIA TREATMENT BY ROUTE OF ADMINISTRATION

6.1 Oral
  6.1.1 Market size and forecast
6.2 Parenteral
  6.2.1 Market size and forecast

PART 7. GLOBAL MARKET FOR MALARIA TREATMENT BY END USER

7.1 Hospitals
  7.1.1 Market size and forecast
7.2 Specialty clinics
  7.2.1 Market size and forecast
7.3 Others
  7.3.1 Market size and forecast

PART 8. GLOBAL MARKET FOR MALARIA TREATMENT BY REGION

8.1 Asia Pacific
  8.1.1 Market size and forecast
8.2 Europe
  8.2.1 Market size and forecast
8.3 North America
  8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
  8.4.1 Market size and forecast

PART 9. KEY COMPETITOR PROFILES

9.1 Abbott Laboratories
9.2 Advanz Pharma Corp.
9.3 Bayer AG
9.4 bioMerieux SA
9.5 Bio-Rad Laboratories, Inc.
9.6 Cadila Healthcare Limited
9.7 F. Hoffmann-La Roche Ltd.
9.8 GlaxoSmithKline plc
9.9 Glenmark Pharmaceuticals Limited
9.10 Ipca Laboratories Limited
9.11 Merck & Co., Inc.
9.12 Meridian Bioscience Inc.
9.13 Novartis International AG
9.14 Olympus Corporation
9.15 Pfizer Inc.
9.16 Sanofi S.A.
9.17 Sun Pharmaceutical Industries Ltd.
9.18 Teva Pharmaceutical Industries Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER

ABOUT GEN CONSULTING COMPANY